Details of the Drug Combinations

General Information of This Drug (ID: DMJ62BV)

Drug Name

Gadopentetate dimeglumine DMJ62BV

Synonyms

Magnevist; Magnevist MRA; Magnevist Syringe; Gadolinium-DTPA-dimeglumine; Gd-DTPA, Schering AG; SH-L-451A; SH-L-545

Indication

Disease Entry	ICD 11	Status	REF
Carcinoma	2A00-2F9Z	Approved	[1]
------------------------------------------------------------------------------------

Drug Type

Small molecular drug

Structure

3D MOL

2D MOL

List of Combinatorial Drugs (CBD) Containing This Drug

2 Clinical Trial Drug Combination(s) Consisting of This drug

DrugCom Name	DrugCom ID	Component Drug	Indication	REF
Gadopentetate dimeglumine + Ropivacaine	DCQMLBT	Ropivacaine	Disorder of Shoulder	[2]
Regadenoson + Gadopentetate dimeglumine	DCWOIP6	Regadenoson	Heart Transplant	[3]
------------------------------------------------------------------------------------

References

1	Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services. 2015
2	ClinicalTrials.gov (NCT02175069) Magnetic Resonance Imaging of Interscalene Plexus Block
3	ClinicalTrials.gov (NCT02597543) Stress Cardiac MRI for Evaluation of Nonspecific Allograft Dysfunction